» Articles » PMID: 8416557

Evaluation of the Prostate and Prostatic Carcinoma with Gadolinium-enhanced Endorectal Coil MR Imaging

Overview
Journal Radiology
Specialty Radiology
Date 1993 Jan 1
PMID 8416557
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Thirteen patients who underwent subsequent radical prostatectomy for prostate cancer were studied with spin-density-T2-weighted and gadolinium-enhanced and unenhanced T1-weighted magnetic resonance (MR) imaging performed with an endorectal surface coil. With gadopentetate dimeglumine, the central gland showed inhomogeneous enhancement due to benign hyperplasia, whereas the peripheral zone demonstrated more uniform and less intense enhancement. With the T1-weighted sequence, depiction of the zonal anatomy, prostate capsule, surgical capsule, fibromuscular stroma, and periprostatic venous plexus was better with contrast enhancement, but these were best demonstrated on T2-weighted images. The trend was similar for prostatic tumor extent and capsular integrity. The seminal vesicles had a septal enhancement pattern and in several patients were best evaluated with enhanced T1-weighted images. These findings suggest that gadopentetate dimeglumine is not warranted for routine use in endorectal MR imaging of the prostate but may be useful for evaluation of the seminal vesicles in selected patients.

Citing Articles

Evolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate.

Latifoltojar A, Dikaios N, Ridout A, Moore C, Illing R, Kirkham A Prostate Cancer Prostatic Dis. 2015; 18(4):343-51.

PMID: 26195470 PMC: 4763162. DOI: 10.1038/pcan.2015.33.


MRI in prostate cancer.

Ghafoori M, Alavi M, Ghasabeh M Iran Red Crescent Med J. 2014; 15(12):e16620.

PMID: 24693403 PMC: 3955518. DOI: 10.5812/ircmj.16620.


Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases.

Liu T, MacDonald T, Jin C, Gold J, Bristow R, Wilson B ACS Nano. 2013; 7(5):4221-32.

PMID: 23544841 PMC: 3667620. DOI: 10.1021/nn400669r.


Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer.

Franiel T, Hamm B, Hricak H Eur Radiol. 2010; 21(3):616-26.

PMID: 21184082 DOI: 10.1007/s00330-010-2037-7.


Prediction of pathological tumor volume in clinically localized prostate cancer: value of endorectal coil magnetic resonance imaging.

Lencioni R, Menchi I, Paolicchi A, Carini M, Amorosi A, Bartolozzi C MAGMA. 1997; 5(2):117-21.

PMID: 9268075 DOI: 10.1007/BF02592242.